Direct transformation of cancer cells into tumor‐reprogrammed APC (TR‐APC) using bone marrow lineage reprogramming activates endogenous tumor‐associated antigens (TAAs)‐specific T cells for leukemia therapy [64]. The gene discussed is APC; the disease is neoplasm.